Rhon-klinikum Ag · XETR:RHK

Rhon-klinikum — Investor Day (April 2019)

33 slides from Rhon-klinikum's investor day presentation, Apr 10, 2019

  1. Slide 1: Capital Markets Day: Corporate Strategy and Financials

    RHÖN-KLINIKUM AG Capital Markets Day Corporate Strategy and Financials 10 April 2019 – Bad Neustadt RHÖN-KLINIKUM AG - First Quarter 2017 Results - as of May 5, 2017 1

  2. Slide 2: Disclaimer

    Disclaimer This presentation has been prepared by RHÖN-KLINIKUM AG (the “Company”) and is for information purposes only. This presentation does not constitute, or form part of, and should not be construed as, an offer, solicitation or invitation to subscribe for, underwrite or otherwise acquire, any

  3. Slide 3: Agenda

    Agenda 1 Transformation and strategy (Stephan Holzinger, CEO/CFO) 2 Business development (Dr. Gunther K. Weiß, COO) 3 Financials and guidance (Julian Schmitt, Head of IR & Treasury) Regulatory framework and 4 (Stephan Holzinger, CEO/CFO) staffing policy RHÖN-KLINIKUM AG – Agenda 3

  4. Slide 4: From Old RHÖN to New RHÖN: The rationale behind the deal

    From Old RHÖN to New RHÖN The rational behind the deal RHÖN-KLINIKUM AG sold 43 clinics in 2014 in an asset deal... New RHÖN  8 clinics in 5 core locations Old RHÖN  Portfolio: Focus on state-of-the-art (before Fresenius/Helios Deal) medicine; treatment of highly severe cases within core business

  5. Slide 5: From Old RHÖN to New RHÖN: New Management Board

    From Old RHÖN to New RHÖN New Management Board  Stephan Holzinger (CEO/CFO) Corporate communications, IR, corporate development, accounting, tax, controlling, corporate finance, HR, legal, data protection, compliance, internal audit, digital transformation and corporate offices  Prof. Dr. Bernd Gr

  6. Slide 6: New RHÖN at a glance: Key figures

    New RHÖN at a glance Key figures 5 sites 8 clinics ~ 5,400 beds € 1.23 bn in sales 7 MVZs Sole private operator of two university clinics ~ 850k patients ~ 17k employees in Germany  5 sites = Bad Neustadt, Frankfurt (Oder), Bad Berka, Giessen and Marburg  8 clinics = Bad Berka , Campus Bad Neustad

  7. Slide 7: New RHÖN at a glance: Market position

    New RHÖN at a glance Market position German hospital market 2)  Total hospital expenditure ~ €93bn  10Y CAGR +4.1% p.a. Germany’s first listed hospital operator Ownership in German  The only publicly listed pure-play on the German acute-care hospital market hospital sector (member of SDAX/IPO 198

  8. Slide 8: New RHÖN at a glance: Our portfolio

    New RHÖN at a glance Our portfolio Bad Berka Bad Neustadt a. d. Saale Frankfurt (Oder) UKGM Giessen/Marburg  Beds 647  Beds 1,579  Beds 852  2,291 beds  Patients ~ 114k*  Patients ~ 94k*  Patients ~ 117k*  Patients ~ 525k patients*  Employees ~ 1,900  Employees ~ 3,500  Employees ~ 1,700

  9. Slide 9: Company's strategic direction: Moving ahead after the transformation

    Company’s strategic direction Moving ahead after the transformation THE NEW RHÖN Campus Expansion strategy strategy Unique cross-sectoral care model Domestic Campus rollout 1st Campus established at Bad Neustadt Business opportunities abroad “In comparison to other private operators, RHÖN has alread

  10. Slide 10: Pillar 1: Campus strategy

    Pillar 1: Campus strategy Our solution: The healthcare Campus of the future Rehab Center (ZrM) Inpatient Center (ZkM) Welcome Center Outpatient Center (ZaM) The RHÖN-KLINIKUM Campus Our future concept for high quality integrated care in rural areas RHÖN-KLINIKUM AG – Corporate strategy 10

  11. Slide 11: Pillar 2: Expansion strategy

    Pillar 2: Expansion strategy Rollout of Campus Concept RHÖN Campus...  Ready to be rolled out to other regions  Prepared for sector-consolidation RHÖN-KLINIKUM AG – Corporate strategy 11

  12. Slide 12: Pillar 3: Digitalisation

    Pillar 3: Digitalisation Digital tools Digital clinical processes Communications & • Mobile doctor‘s visit data transfer • Medical Cockpit • “Physician‘s Portal” • Digital self-anamnesis • Medical image data exchange • Digital medical archive and teleradiology • Digital nurse call center • Tele-stro

  13. Slide 13: Pillar 4: Telemedics

    Pillar 4: Telemedics An additional growth opportunity for RHÖN RHÖN-KLINIKUM AG enters future market of telemedics with Medgate  Memorandum of Understanding on extensive cooperation for telemedics signed; New-Co in the founding process  RHÖN-KLINIKUM AG will hold the majority of New-Co with 51%, M

  14. Slide 14: Strategic shareholder base

    Strategic shareholder base Shareholder structure as of 11 March 2019, according to the most recent notifications of voting rights at that time 25.2% 24.5%* B. Braun 24.5% Free Float 5.2% 75.5% Landeskrankenhilfe Strategic Investors 5.4% 25.1% Ingeborg Münch Asklepios 14.6% Eugen Münch/HCM SE * Share

  15. Slide 15: Agenda

    Agenda 1 Transformation and strategy (Stephan Holzinger, CEO/CFO) 2 Business development (Dr. Gunther K. Weiß, COO) 3 Financials and guidance (Julian Schmitt, Head of IR & Treasury) Regulatory framework and 4 (Stephan Holzinger, CEO/CFO) staffing policy RHÖN-KLINIKUM AG – Agenda 15

  16. Slide 16: Business development: Highlights

    Business development Highlights RHÖN-KLINIKUM Campus Bad Neustadt opened on 6 Dec. 2018 RHÖN safeguards future of Marburg Particle Therapy Implementation of Center (MIT) important digital projects Catalogue of measures Agreement on separate successfully implemented: accounting successfully use of se

  17. Slide 17: Business development: Campus Bad Neustadt

    Business development Campus Bad Neustadt 12/2018 – Opening of the new Campus Bad Neustadt  One of the largest individual construction projects in the company's 45-year history  Ideal implementation of the Campus Concept for holistic health care in rural areas for the first time 12-2018/01-2019 – S

  18. Slide 18: Business development: Frankfurt (Oder)

    Business development Frankfurt (Oder) Strategic realignment of Health Campus Frankfurt (Oder)  At our Frankfurt (Oder) site a second health Campus is being built  Center for Outpatient Medicine  Cooperations e.g. standby doctor‘s office, MVZ, therapy offices  18 practices on the Campus  180,000

  19. Slide 19: Business development: Bad Berka

    Business development Bad Berka 120 years of clinical medicine  With the establishment of the former lung sanatorium, the foundation stone was laid for today's top medicine provider of Bad Berka 45 years interdisciplinary cardiac center  One of the largest and best recognised heart centers in Germa

  20. Slide 20: Business development: University Hospital Giessen

    Business development University Hospital Giessen Cardio-lung cluster of excellence "Cardio-Pulmonary System" (ECCPS)  Only cluster of excellence for heart and lung research in Hesse remains a stable factor  Unique selling proposition throughout Germany Foundation of the Intergenomics Network  Cen

  21. Slide 21: Business development: University Hospital Marburg

    Business development University Hospital Marburg RHÖN-KLINIKUM AG secures the future of the Marburg Particle Therapy Center (MIT)  Acquisition of the majority interest in MIT from Heidelberg University Hospital (75.1%)  Introduction of a successful new chapter for MIT  Positive signal for the Mar

  22. Slide 22: New separate accounting contract: The pact for the future

    New separate accounting contract The pact for the future “Groundbreaking agreement on the separate accounting signed with the State of Hesse in 2017, contract in force!”  New separate accounting contract became effective in Q3 2018 after third party comparison on a arm’s length principle by KPMG wa

  23. Slide 23: Agenda

    Agenda 1 Transformation and strategy (Stephan Holzinger, CEO/CFO) 2 Business development (Dr. Gunther K. Weiß, COO) 3 Financials and guidance (Julian Schmitt, Head of IR & Treasury) Regulatory framework and 4 (Stephan Holzinger, CEO/CFO) staffing policy RHÖN-KLINIKUM AG – Agenda 23

  24. Slide 24: Financials: FY 2018 key figures

    Financials FY 2018 key figures Volumes Revenues  +1.6% more treated patients +1.8% 1,232.9  Total number of cases 850,147 1,211.1  Reduced number of inpatient cases (-0.4%) outperformed by increased number of ambulatory treatments (+2.3%) FY 2017 FY 2018 in million € Earnings & Cash EBITDA +28.3%

  25. Slide 25: Financials: P&L key figures of FY 2018

    Financials P&L key figures of FY 2018 o Despite regulatory interventions by the legislator such as the catalogue effect and FDA as well as P&L (in €m) 2018 2017 Delta MDK corrections and the trend towards outpatient Revenues 1,233 1,211 +1.8% treatments, sales rose by 1.8% o Personnel expenses in 20

  26. Slide 26: Financials: Balance sheet as of December 2018

    Financials Balance sheet as of 31 December 2018 €1,589m €1,589m 65% €1,039m Non-current assets €1,159m Equity ratio Equity 73% €550m 35% Current assets €117m Non-current liabilities 7% €313m €247m Cash Current liabilities 20% Assets Equity & liabilities Solid balance sheet and  Strong equity ratio

  27. Slide 27: Financials: Dividend proposal

    Financials Dividend proposal Management Board and Supervisory Board jointly propose to the AGM to distribute a dividend of €0.29 per share (+ 32%) compared to the previous year Based on the currently outstanding number of shares in the amount of 66.94 million, the total dividend will amount to €19.4

  28. Slide 28: Outlook 2019

    Outlook 2019 GUIDANCE Group REVENUES € 1.30bn +/- 5% 2019 Group EBITDA € 117.5m to € 127.5m Assumptions and key levers*  +1.8% DRG price effect on group revenues  +2.8% DRG volume growth on group revenues after catalogue effect  Further growth from additional charges, elective services and outpat

  29. Slide 29: Agenda

    Agenda 1 Transformation and strategy (Stephan Holzinger, CEO/CFO) 2 Business development (Dr. Gunther K. Weiß, COO) 3 Financials and guidance (Julian Schmitt, Head of IR & Treasury) Regulatory framework and 4 (Stephan Holzinger, CEO/CFO) staffing policy RHÖN-KLINIKUM AG – Agenda 29

  30. Slide 30: Regulatory framework: Headwinds for German hospital operators

    Regulatory framework Headwinds for German hospital operators PpUGV PpSG Discounts on DRG-remuneration Minimum staffing levels in Carve-out of nursing nursing care in remuneration from existing 4 care intensive units DRG system  FDA valid since 1st January 2019 „Pflexit“ with effect of 1st January 2

  31. Slide 31: Staffing policy: Recruitment offensive for nursing care

    Staffing policy Recruitment offensive for nursing care Incentives  2018 Start of an exchange program for nursing students between Bad Berka and the University Hospital Marburg  Assistance in finding accommodation and discounted offers  Support in finding kindergartens and nursery spaces  Parcel

  32. Slide 32: Staffing policy: Training curriculum

    Staffing policy Training curriculum Digital Medicine, eHealth and Telemedicine  Cooperation between Justus-Liebig-University Giessen (JLU) and RHÖN-KLINIKUM AG with participation of the Technical University Hessen (THM) and the Center for Telemedicine in Bad Kissingen (ZTM)  Improving competencies

  33. Slide 33: Appendix: IR contact information

    Appendix IR contact information Contact Julian Schmitt Head of Investor Relations & Treasury tel +49 9771 65 1536 email ir@rhoen-klinikum-ag.com RHÖN-KLINIKUM AG – Appendix 33

Rhön-Klinikum — Investor Day (April 2019) on 6ix